Goodwin Daniel L Pfizer Inc Transaction History

Goodwin Daniel L

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $181,467 - $215,163	3,900 New	3,900 $204,000
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $170,784 - $211,623	-3,733 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $154,247 - $228,646	3,733 New	3,733 $220,000
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $153,775 - $199,401	-4,733 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$32.98 - $35.16 $156,094 - $166,412	4,733 New	4,733 $171,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Goodwin Daniel L, based on Form 13F filings with the SEC.

Stay updated on Goodwin Daniel L with notifications on news.